Skip to main content
Supplement ScienceSupplementScience

Uridine Side Effects & Safety

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Generally well-tolerated at recommended doses
  • Mild digestive discomfort
  • Rare: headache (may indicate need for choline co-supplementation)
  • Rare: fatigue or brain fog at excessive doses
  • Theoretically may feed cancer cell growth due to nucleotide role in cell proliferation — no clinical evidence of this at supplement doses

Drug & Supplement Interactions

  • No significant drug interactions reported at supplemental doses
  • Synergistic with DHA (omega-3) and choline sources (Alpha-GPC, CDP-Choline)
  • Theoretical concern with nucleotide-targeting chemotherapy drugs — avoid during cancer treatment without oncologist approval

Maximum Dose

Do not exceed: 500mg UMP/day or 100mg TAU/day (limited long-term safety data at higher doses)

Full Uridine Guide

References

  1. RCTCansev M, Watkins CJ, van der Beek EM, Wurtman RJ (2005). Oral uridine-5'-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Research. DOI PubMed
  2. Jensen JE, Daniels M, Reppermund S, et al. (2008). Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Experimental and Clinical Psychopharmacology.
  3. ObservationalXu X, Zhang X, Cheng S, Li Q, et al. (2023). Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study.. Scientific reports. DOI PubMed
  4. Achour B, Rostami-Hodjegan A, Barber J (2014). Protein expression of various hepatic uridine 5'-diphosphate glucuronosyltransferase (UGT) enzymes and their inter-correlations: a meta-analysis.. Biopharmaceutics & drug disposition. DOI PubMed
  5. RCTMonfort J, Carrión-Barberà I, Tío L, Marante J, et al. (2024). Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients.. Nutrients. DOI PubMed
  6. Janson E, Koolschijn PCMP, Schipper L, Boerma TD, et al. (2024). Dolphin CONTINUE: a multi-center randomized controlled trial to assess the effect of a nutritional intervention on brain development and long-term outcome in infants born before 30 weeks of gestation.. BMC pediatrics. DOI PubMed
  7. Acosta L, Byham-Gray L, Kurzer M, Samavat H (2023). Hepatotoxicity with High-Dose Green Tea Extract: Effect of Catechol-O-Methyltransferase and Uridine 5'-Diphospho-glucuronosyltransferase 1A4 Genotypes.. Journal of dietary supplements. DOI PubMed
Show 3 more references
  1. ReviewBaumel BS, Doraiswamy PM, Sabbagh M, Wurtman R (2021). Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review.. Neurology and therapy. DOI PubMed
  2. RCTBattaglia S, De Santis S, Rutigliano M, Sallustio F, et al. (2021). Uridine and pyruvate protect T cells' proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study.. Scientific reports. DOI PubMed
  3. Wurtman RJ, Cansev M, Sakamoto T, Ulus IH (2009). Use of phosphatide precursors to promote synaptogenesis. Annual Review of Nutrition. DOI PubMed